论文部分内容阅读
Identification of an Integrin α6-Targeted Peptide for Nasopharyngeal Carcinoma-Specific Nanotherapeu
【作 者】
:
【机 构】
:
Sun Yat-sen University Cancer Center Columbia Uni
【出 处】
:
2019中国肿瘤学大会
【发表日期】
:
2019年7期
其他文献
目的 本研究旨在研究PLK1 抑制剂BI2536 联合STAT3 抑制剂Stattic 通过MYC 诱导胶质瘤细胞凋亡的分子机制,为靶向PLK1 联合STAT3 治疗胶质瘤提供科学依据。
Apatinib inhibits cell proliferation and induces autophagy via the PI3K/Akt signaling pathway in hum
Objective Objective: PTC is the most common type of thyroid cancer and has a favorable prognosis.However,patients with metastatic radioiodine-refractory papillary thyroid carcinoma(PTC)have limited op
目的 EGFRvⅢ 是胶质母细胞瘤中最常见的突变,具有促进胶质母细胞瘤进展的多种活性。本研究旨在通过体内、外实验揭示SRC 家族激酶抑制剂Saracatinib 对EGFRvⅢ 阳性胶质瘤干细胞的抑制作用。
目的 胃癌是我国最常见的恶性肿瘤,在我国其发病率和死亡率居各类肿瘤的首位,因此,寻找胃癌的治疗靶点是当前肿瘤研究领域的热点.P21 活化蛋白激酶1(p21-activated kinase 1,PAK1)作为I 类PAK 家族的代表,是进化上保守的丝氨酸/苏氨酸蛋白激酶,在肿瘤细胞信号转导过程中具有枢纽作用,因此已成为有效的肿瘤治疗靶点.但目前针对该靶点抑制剂的研究正处于起步阶段.
Nek2B activates the wnt pathway and promotes triplenegative breast cancer chemotherapy-resistance by
Objective The molecular mechanism of chemotherapy-resistance in triple-negative breast cancer(TNBC)is unclear.Centrosomal kinase Nek2B is the only Nek2 isomer through the whole process of mitosis.Our
目的 血管内皮生长因子(vascular endothelial growth factor,VEGF)是目前已知的最重要的血管生成调节因子,VEGF 与其受体(vascular endothelial growth factor receptor,VEGFR)特异性结合,调节着血管及肿瘤血管的生成。本研究靶向vegf 及其受体vegfr2 基因 siRNA 对小鼠黑色素瘤细胞B16F10 移植瘤
Mifepristone Derivative FZU-00,003 Suppresses Triplenegative Breast Cancer Cell Growth partially via
Objective Triple-negative breast cancer(TNBC)is one of the most malignant breast cancers lacking targeted therapeutics currently due to the heterogeneity of the disease,the absence of well-defined mol
Artesunate exhibits synergistic anti-cancer effects with cisplatin on lung cancer A549 cells by inhi
Objective Artesunate(ART)has been used extensively as anti-malarial drugs worldwide.Besids,it has also been reported to have anti-cancer activities.However,few studies have investigated the exact anti
Survivals in Advanced EGFR-Mutant NSCLC Patients Treated with First-Generation EGFR TKIs followed by
目的 肿瘤是一类严重危害人类健康的疾病。我国近几年癌症发病率逐年增加,恶性程度也越来越高,传统的肿瘤治疗方法存在毒副作用大、易产生耐药性等缺点。